Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-01-05 @ 6:17 PM
Study NCT ID:
NCT03524092
Status:
COMPLETED
Last Update Posted:
2025-10-14
First Post:
2018-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-10
First Submit QC Date:
None
Study First Post Date:
2018-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-02
Results First Submit QC Date:
None
Results First Post Date:
2022-11-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-01
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED